Article

Free webinars for patients and survivors

Author(s):

Fight Colorectal Cancer is hosting two free webinars for cancer patients, survivors, caregivers and advocates. Fight Colorectal Cancer, formerly the Colorectal Cancer Coalition, is a nonprofit organization dedicated to supporting and educating people with colorectal cancer. Members advocate on behalf of patients and caregivers to increase research funding and influence policy and legislative change. CURE's fall issue will feature an article on people who have made cancer their mission. If you are interested in doing the same, the webinar "Couch Potato Advocacy: 3 Things You Can Do at Home to Help the Fight" will steer you in that direction. It features David Pugach, the American Cancer Society Cancer Action Network's associate director of federal relations, providing "tips on how to take your experience as a cancer fighter and use it to make a difference for all those in the fight of their lives." This webinar is on August 17, 2011, from 8:00 PM to 9:30 PM EDT. To register, click here. Getting cancer is tough enough without having to deal with losing a job or insurance. Learn what your rights are at "Cancer and the Law" hosted by Laura Riley of the Cancer Legal Resource Center (CLRC). Riley will discuss common cancer-related legal issues for patients and survivors, such as employment rights, health insurance options, disability insurance and taking off work for medical reasons. The CLRC is a nonprofit that provides free legal assistance and counseling to cancer patients, survivors, friends and family. This webinar takes place on September 21, 2011, from 8:00 PM to 9:30 PM EDT. To register, click here. And for more information on Fight Colorectal Cancer, you can access their website at fightcolorectalcancer.org.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.
Image of doctor.
Image of woman.